Significant reduction in time to market for new products.

Objective

Objective

  • Noticeable reduction in development and approval times for new products
  • Measurably shorter time to market

Approach

Approach

  • Analysis of development and release processes
  • Focos on clinical value and intended use
  • Process model overhaul

Results

Results

  • New product success rate up by 30 %
  • Turnaround time down by 20 %

Contact

Jan Eilers
+49 241 51031 0
jan.eilers@schuh-group.com


Back


This website is using cookies to provide a good browsing experience.

These include essential cookies that are necessary for the operation of the site, as well as others that are used only for anonymous statistical purposes, for comfort settings or to display personalized content. You can decide for yourself which categories you want to allow. Please note that based on your settings, not all functions of the website may be available.

This website is using cookies to provide a good browsing experience.

These include essential cookies that are necessary for the operation of the site, as well as others that are used only for anonymous statistical purposes, for comfort settings or to display personalized content. You can decide for yourself which categories you want to allow. Please note that based on your settings, not all functions of the website may be available.

Your cookie preferences have been saved.